Covered recipient · General Payments record
DENA KAMMAN-RASCHE
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2025
$4,369.83
- Reported across 220 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,190.02 | 61 |
| Education | $108.98 | 2 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| PFIZER INC. | $134.23 | 10 |
| Incyte Corporation | $120.61 | 2 |
| Acerta Pharma LLC | $92.20 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $89.83 | 4 |
| ABBVIE INC. | $80.65 | 4 |
| Daiichi Sankyo Inc. | $72.83 | 3 |
| Gilead Sciences, Inc. | $70.04 | 3 |
| Janssen Biotech, Inc. | $56.55 | 3 |
| Celgene Corporation | $55.48 | 3 |
| Geron Corporation | $47.01 | 2 |
| Genmab U.S., Inc. | $46.34 | 2 |
| Takeda Pharmaceuticals U.S.A., Inc. | $43.72 | 2 |
| GENZYME CORPORATION | $43.41 | 2 |
| ARRAY BIOPHARMA INC | $31.32 | 2 |
| Amgen Inc. | $24.56 | 1 |
| Syndax Pharmaceuticals, Inc. | $23.76 | 1 |
| Caris MPI, Inc. | $21.98 | 1 |
| GlaxoSmithKline, LLC. | $21.80 | 1 |
| Adaptive Biotechnologies Corporation | $21.80 | 1 |
| EISAI INC. | $21.70 | 1 |
| SERVIER PHARMACEUTICALS LLC | $21.42 | 1 |
| Genentech USA, Inc. | $21.18 | 1 |
| ACCORD HEALTHCARE, INC. | $20.84 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.40 | 1 |
| Merck Sharp & Dohme Corporation | $18.93 | 1 |
| BeOne Medicines USA, Inc. | $17.07 | 1 |
| Janssen Pharmaceuticals, Inc | $15.99 | 1 |
| Legend Biotech USA Inc. | $15.85 | 1 |
| BeiGene USA, Inc. | $14.98 | 1 |
| Astellas Pharma US Inc | $13.52 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (63)
Sorted by paying entity, then date · as published by CMS
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2021, 2022, 2023, 2024, 2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.